Open access · CC-BY
via OpenAlex
Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson’s iPSC-derived dopamine neurons
Federico Zambon, Marta Cherubini, Hugo J. R. Fernandes, Charmaine Lang, Brent James Ryan, Viola Volpato, Nora Bengoa‐Vergniory, Siv Vingill, Moustafa Attar, Heather Booth, Walther Haenseler, Jane Vowles, Rory J. Bowden, Caleb Webber, Sally A. Cowley
Human Molecular Genetics · 2019 · ▲ 165 citations
Abstract
Parkinson's disease (PD) is the second most common neurodegenerative disorder and a central role for α-synuclein (αSyn; SNCA) in disease aetiology has been proposed based on genetics and neuropathology. To better understand the pathological mechanisms of αSyn, we generated induced pluripotent stem cells (iPSCs) from healthy individuals and PD patients carrying the A53T SNCA mutation or a triplication of the SNCA locus and differentiated them into dopaminergic neurons (DAns). iPSC-derived DAn from PD patients carrying either mutation showed increased intracellular αSyn accumulation, and DAns from patients carrying the SNCA triplication displayed oligomeric αSyn pathology and elevated αSyn extracellular release. Transcriptomic analysis of purified DAns revealed perturbations in expression of genes linked to mitochondrial function, consistent with observed reduction in mitochondrial respiration, impairment in mitochondrial membrane potential, aberrant mitochondrial morphology and decreased levels of phosphorylated DRP1Ser616. Parkinson's iPSC-derived DAns showed increased endoplasmic reticulum stress and impairments in cholesterol and lipid homeostasis. Together, these data show a correlation between αSyn cellular pathology and deficits in metabolic and cellular bioenergetics in the pathology of PD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/hmg/ddz038
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Zambon, F., Cherubini, M., Fernandes, H.J.R., Lang, C., Ryan, B.J., Volpato, V., Bengoa‐Vergniory, N., Vingill, S., Attar, M., Booth, H., Haenseler, W., Vowles, J., Bowden, R.J., Webber, C., Cowley, S.A., & Wade‐Martins, R. (2019). Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson’s iPSC-derived dopamine neurons. <em>Human Molecular Genetics</em>. https://doi.org/10.1093/hmg/ddz038
Vancouver
Zambon F, Cherubini M, Fernandes HJR, Lang C, Ryan BJ, Volpato V, et al. Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson’s iPSC-derived dopamine neurons. Human Molecular Genetics. 2019. doi:10.1093/hmg/ddz038.
BibTeX
@article{federico2019Cellul,
title = {Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson’s iPSC-derived dopamine neurons},
author = {Federico Zambon and Marta Cherubini and Hugo J. R. Fernandes and Charmaine Lang and Brent James Ryan and Viola Volpato and Nora Bengoa‐Vergniory and Siv Vingill and Moustafa Attar and Heather Booth and Walther Haenseler and Jane Vowles and Rory J. Bowden and Caleb Webber and Sally A. Cowley and Richard Wade‐Martins},
journal = {Human Molecular Genetics},
year = {2019},
doi = {10.1093/hmg/ddz038},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Molecular Sciences 2023
Open access · CC-BY
YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
GeroScience 2026
Open access · CC-BY
Lipid-laden endothelial cells exhibit a transcriptomic signature linked to blood–brain barrier dysfunction, metabolic reprogramming, and increased inflammation in the aging brain
Frontiers in Molecular Neuroscience 2017
Open access · CC-BY
Interplay of Energetics and ER Stress Exacerbates Alzheimer's Amyloid-β (Aβ) Toxicity in Yeast
Journal of Clinical Investigation 2015
Open access · OA
shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson’s disease model
Molecular Genetics and Metabolism Reports 2019
Open access · CC-BY
Feasibility of cellular bioenergetics as a biomarker in porphyria patients
Acta Neuropathologica 2023
Open access · CC-BY